Form 4: Lyell Immunopharma COO Sells Shares
Insider Transaction (Form 4)
Stephen J. Hill, Chief Operating Officer of Lyell Immunopharma, Inc., sold 89 shares of common stock on August 10, 2026 for $14.34 per share.
Summary
- Open-market sale: disposed of 89 Common Stock at $14.34 ($1,276) on August 10, 2026; holds 17,805 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $1,276 of stock on the open market.
Insider Transactions
Stephen J. Hill — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | Common Stock | 89 | $14 | $1.3K | 17,805 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (89 shares) |
Keywords
insider transaction, Form 4, LYEL, Lyell Immunopharma, Inc., bearish, Stephen J. Hill
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.